Alpha Cognition (ACOG) Stock News
$ACOG · NASDAQ · 2 stories in 30 daysBORSA has published 2 stories on Alpha Cognition (ACOG) in the past 30 days. BORSA’s news read on ACOG is bullish at 60/100, −1 over 24 hours, based on 1 company event over the past 7 days. ACOG last closed at $8.80 on Oct 13, down 2.00% over five sessions and up 1.03% over the past month. Alpha Cognition’s next earnings report is scheduled for Thursday, Nov 12.
The wire on $ACOG
newest first · updated · direct subject stories onlyAlpha Cognition announces publication of US patent application for ZUNVEYL manufacturing process
Alpha Cognition (ACOG) said the USPTO published its patent application covering proprietary manufacturing technology for benzgalantamine, the active ingredient in ZUNVEYL. The application aims to improve efficiency, quality, and scalability. CEO Michael McFadden said it supports the company's IP strategy.
bullish 65 · impact 30